Cargando…
NCPDP recommendations for dose accumulation monitoring in the inpatient setting: Acetaminophen case model, version 1.0
PURPOSE: Best practices and guidance are provided for improved electronic detection and alerting of inadvertent supratherapeutic cumulative doses of acetaminophen and other medications with narrow therapeutic ranges in inpatient settings. SUMMARY: Despite the use of medication safety technologies, o...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477888/ https://www.ncbi.nlm.nih.gov/pubmed/27267535 http://dx.doi.org/10.2146/ajhp160215 |
_version_ | 1783413100540592128 |
---|---|
collection | PubMed |
description | PURPOSE: Best practices and guidance are provided for improved electronic detection and alerting of inadvertent supratherapeutic cumulative doses of acetaminophen and other medications with narrow therapeutic ranges in inpatient settings. SUMMARY: Despite the use of medication safety technologies, overdosage and associated sentinel events continue to be serious problems in many inpatient settings. The tools needed to monitor and employ dose alerts, accumulators, and warning systems are available to reduce inadvertent overdose. Required are staff training and the implementation of processes that provide guidance and documentation of the drug reconciliation process from admittance to discharge for safe patient passage through the various transitions of care. Recommendations to achieve optimal patient safety outcomes include the adoption and integration of available technologies with full functionality configured to meet the institution’s policies and processes, initial training and retraining of all staff who use these systems, continuing education of the patient care staff on the dosing safety requirements, and assigning a prominent role to the clinical pharmacist in the entire drug-use and reconciliation process. CONCLUSION: The key factors contributing to inadvertent overdosage in inpatient settings include a lack of recognition of recommended maximum daily dosages; failure to optimally communicate medication information at transitions of care; failure to optimally implement medication safety technologies, particularly dose accumulator calculation features and associated alerts; and alert fatigue and override. |
format | Online Article Text |
id | pubmed-6477888 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-64778882019-04-25 NCPDP recommendations for dose accumulation monitoring in the inpatient setting: Acetaminophen case model, version 1.0 Am J Health Syst Pharm Special Feature PURPOSE: Best practices and guidance are provided for improved electronic detection and alerting of inadvertent supratherapeutic cumulative doses of acetaminophen and other medications with narrow therapeutic ranges in inpatient settings. SUMMARY: Despite the use of medication safety technologies, overdosage and associated sentinel events continue to be serious problems in many inpatient settings. The tools needed to monitor and employ dose alerts, accumulators, and warning systems are available to reduce inadvertent overdose. Required are staff training and the implementation of processes that provide guidance and documentation of the drug reconciliation process from admittance to discharge for safe patient passage through the various transitions of care. Recommendations to achieve optimal patient safety outcomes include the adoption and integration of available technologies with full functionality configured to meet the institution’s policies and processes, initial training and retraining of all staff who use these systems, continuing education of the patient care staff on the dosing safety requirements, and assigning a prominent role to the clinical pharmacist in the entire drug-use and reconciliation process. CONCLUSION: The key factors contributing to inadvertent overdosage in inpatient settings include a lack of recognition of recommended maximum daily dosages; failure to optimally communicate medication information at transitions of care; failure to optimally implement medication safety technologies, particularly dose accumulator calculation features and associated alerts; and alert fatigue and override. Oxford University Press 2016-08 /pmc/articles/PMC6477888/ /pubmed/27267535 http://dx.doi.org/10.2146/ajhp160215 Text en Copyright © 2016 by the National Council for Prescription Drug Programs (NCPDP) This document may be freely redistributed in its entirety provided that the copyright notice is not removed. It may not be sold for profit or used in commercial documents without the written permission of the copyright holders. This document is provided “as is” without any express or implied warranty. This document is also being published by the National Council for Prescription Drug Programs. |
spellingShingle | Special Feature NCPDP recommendations for dose accumulation monitoring in the inpatient setting: Acetaminophen case model, version 1.0 |
title | NCPDP recommendations for dose accumulation monitoring in the inpatient setting: Acetaminophen case model, version 1.0 |
title_full | NCPDP recommendations for dose accumulation monitoring in the inpatient setting: Acetaminophen case model, version 1.0 |
title_fullStr | NCPDP recommendations for dose accumulation monitoring in the inpatient setting: Acetaminophen case model, version 1.0 |
title_full_unstemmed | NCPDP recommendations for dose accumulation monitoring in the inpatient setting: Acetaminophen case model, version 1.0 |
title_short | NCPDP recommendations for dose accumulation monitoring in the inpatient setting: Acetaminophen case model, version 1.0 |
title_sort | ncpdp recommendations for dose accumulation monitoring in the inpatient setting: acetaminophen case model, version 1.0 |
topic | Special Feature |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477888/ https://www.ncbi.nlm.nih.gov/pubmed/27267535 http://dx.doi.org/10.2146/ajhp160215 |